Injecting the Immune System: Long-Acting TLR7/8 Agonist Shows Promise Against Oral Cancer
A small German cohort study reports that injecting a slow-release TLR7/8 agonist into oral tumors before surgery, combined with systemic ...
A small German cohort study reports that injecting a slow-release TLR7/8 agonist into oral tumors before surgery, combined with systemic ...
Researchers found that low levels of Bifidobacterium inside liver tumors are associated with very early recurrence after surgery in hepatocellular ...
By integrating bulk and single-cell RNA sequencing with machine learning, researchers in China have identified a nine-gene macrophage signature that ...
A preclinical study reports that combining the kinase inhibitor regorafenib with the small-molecule PD-1/PD-L1 inhibitor BMS-1 synergistically suppresses the growth, ...
New research shows that the pyroptosis executor GSDME is upregulated in gastric cancer, where it correlates with advanced stage, immunosuppressive ...
A mannose-decorated zinc metal-organic framework nanovaccine delivering the tumor antigen CLDN6 reprograms immunosuppressive macrophages in lung tumors into antigen-presenting cells ...
A machine-learning model built on seven genes tied to mitochondrial outer membrane permeabilization stratifies lung adenocarcinoma patients into distinct survival ...
By integrating single-cell and bulk RNA sequencing with machine learning and laboratory validation, researchers have identified MAP1LC3B and HSD17B10 as ...
A new review in the Journal of Translational Medicine details how post-translational modifications such as ubiquitination, phosphorylation, acetylation, and SUMOylation ...
A phase II pilot trial found that the IDO1 inhibitor epacadostat safely reduced kynurenine-to-tryptophan ratios in advanced melanoma patients but ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine